BenchSci lands Series B
BenchSci, which uses machine learning to identify and resolve preclinical research inefficiencies in drug discovery, has raised US$22 million in Series B financing.
BenchSci, which uses machine learning to identify and resolve preclinical research inefficiencies in drug discovery, has raised US$22 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination
